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Intracellular Free Zinc Ion Increase Triggers Hyperglycemia-Induced
Cardiomyocyte Dysfunction through Endoplasmic Reticulum Stress
Erkan Tuncay, Figen Amber Cicek, Aysegul Toy, Belma Turan.
Biophysics, Ankara University School of Medicine, Ankara, Turkey.
Intracellular free Zn2þ concentration, (Zn2þ)i is less than one nanomolar in
resting cardiomyocytes. Very little is known about mechanisms controlling
(Zn2þ)i distribution and variations during cardiac function although in vitro
oxidant exposures to cardiomyocytes caused 30-fold increase in (Zn2þ)i but
only 2-fold in (Ca2þ)i while thesewere 2-fold and 1.2-fold under hyperglycemia,
respectively. Since it has been mentioned that Zn2þ homeostasis is involved in
unfolded protein response (endoplasmic reticulum stress, ERS) under salt stress,
we aimed to investigate whether a hyperglycemia-induced increased level of
basal (Zn2þ)i can trigger an ERS, which in turn induces marked cardiomyocyte
dysfunction.Whenwe enforced Zn2þ influx into cytosol by using zinc ionophore
pyrithione (ZnPT), mechanical and electrical activities of cardiomyocytes
impaired in a concentration-dependent manner, similar to hyperglycemia. Incu-
bation of cardiomyocytes with ZnPT exerted also hyperphosphorylation in
RyR2, PKA, and CaMKII in a concentration-dependent manner, again similar
to hyperglycemia. The levels of some ERS chaperon proteins and ERS-
mediated apoptosis marker proteins (Calregulin, GRP 78, Bcl-2 and PUMA)
were also examined and compared in between ZnPT-incubated cardiomyocytes
and STZ-diabetic rat cardiomyocytes. The chaperon protein levels were found to
be increased in diabetics and also in ZnPT-incubated ones in a concentration
dependent-manner.We also observed a similar parallel correlation between these
two-group experiments for anti-apoptotic protein Bcl-2 and apoptotic one
PUMA. Taken into consideration diabetes-induced cardiac dysfunction due to,
in part, increased basal (Zn2þ)i and in vitro increased (Zn
2þ)i-induced cardio-
myocyte dysfunction present a possible triggering role of increased (Zn2þ)i in
hyperglycemia-induced cardiomyocyte dysfunction through ERS.
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KD Channel-Interacting Protein 2 Deficient mice have a Rate Dependent
Prolongation of Left Ventricular CA2D Transients
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In the heart, Kþ channel-interacting protein 2 (KChIP2) stabilizes Kv4
channels in the membrane resulting in larger transient outward potassium
currents (Ito). Recently it has been demonstrated that KChIP2 also enhances
Cav1.2 and that the KChIP2-/- mouse has reduced inward L-type Ca2þ current.
In this study, we test the impact of KChIP2-/- on cardiac contraction and on
underlying Ca2þ transients.
Through ultrasound examination, we found comparable left ventricular ejection
fraction and fractional shortening in the heart of wild-type (WT) and KChIP2-/-
mice, indicating that the function of the left ventricle was not impaired despite
reduced L-type Ca2þ current. Confocal line scan Ca2þ imaging was performed
using the Cal-520TM fluorophore. Whole-cell Ca2þ transients were recorded
from disaggregated left ventricular cardiomyocytes at 37C, field stimulated at
cycle lengths between 80 and 1000 ms. A decrease in the relative peak of the
Ca2þ transient was found in KChIP2-/- versus WT (0.5850.06 vs. 0.7150.07
F/F0, P<0.05) and the time to 50% decay of the transient was prolonged
(13355 vs. 12153 ms, P<0.05). These differences were rate-dependent and
diminished at cycle lengths shorter than 1000ms. However, at the fastest pacing
rate more cardiomyocytes were alternating in KChIP2-/- compared with WT
(cycle length: 80 ms;WT: 12/18, KChIP2-/-: 23/23). The fractional Ca2þ release
was not different between the two genotypes, suggesting that the differences in
Ca2þ transients are not a result of differential SR load.
In conclusion, although cardiac contraction is not impaired in the KChIP2-/-
mouse, some abnormal Ca2þ handling is apparent in individual KChIP2-/-
cardiomyocytes, including a higher propensity to develop Ca2þ transient alter-
nans. If this is manifested significantly at the tissue level, it could contribute to
the development of repolarization gradients across the myocardium.
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France, 3Radio-oncology Laboratory, CHUV, Lausanne, Switzerland.As a result of more effective therapies, more patients recover from cancer.
However, often they develop cardiotoxicity manifested, among others, as
heart failure. Doxorubicin (Dox), a widely used and highly effective cancer
chemotherapeutic agent, and radiation therapy (RT), when directed to the
thorax, can affect cardiac function. Because intracellular Ca2þ fluxes underlie
cardiac function, we investigated intracellular Ca2þ handling in mice treated
with doxorubicin (Dox) or chest radiotherapy (RT). 12 weeks old, C57BL/6
male mice received 3 i.v. injections of 4 mg/Kg Dox each, reaching a cumu-
lative dose of 12mg/kg of Dox. Data was obtained at 2, 6 and 15 weeks after
last injection. RT-treated mice were locally irradiated with 2 and 16Gy local-
ized to the heart, and experiments performed 20 and 50 weeks after irradia-
tion. M-mode Echocardiography showed a significant reduction of the
ejection fraction (EF) at 15w after last injection of Dox. Consistently, the
amplitude of [Ca2þ]i transients was decreased (F/F0: 4.1050.25, n=11 con-
trol cells, vs 3.2250.14, n=15 Dox, p<0.01) and slowed (Tau in ms:
138.9856.17, n=11 control vs 169.63511.91, n=15 Dox, p<0.05) at 15w
with a significant increase in the frequency of Ca2þ sparks, but without
changes on the SR Ca2þ content. RT induced a LV enlargement associated
with a significant reduction of EF in low and high dose irradiated mice group
at both time lapses. However, Ca2þ handling was minimally affected by RT.
After 50w of 16Gy RT, we observed a faster decay of [Ca2þ]i transients with
unaltered amplitude and SR Ca2þ content. Our results indicate that the
depressed cardiac function after Dox treatment involves [Ca2þ]i transient
reduction, while in RT-induced cardiotoxicity the Ca2þ alteration may not
be involved likewise.
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Anthracyclines are powerful chemotherapy agents, whose use is limited due
to the onset of potentially fatal cardiotoxicity which includes arrhythmo-
genesis and heart failure. Several proteins important in intracellular Ca2þ sig-
nalling have been identified as drug binding targets, including the cardiac
ryanodine receptor Ca2þ release channel (RyR2), the Ca2þ binding protein
calsequestrin (CSQ2) and the Sarco/Endoplasmic Reticulum Ca-ATPase
(SERCA2a). The effects of the drug metabolites have been poorly character-
ized but are believed to be important in the devastating cardiac effects of these
drugs.
The functional effect of doxorubicin and its metabolite, doxorubicinol on
RyR2 was assessed by adding clinically relevant drug concentrations to single
RyR2 channels in lipid bilayers. Both drugs caused biphasic modulation
of RyR2 activity where there was an early increase in channel activity
followed by a later, inhibitory phase. RyR2 channel activation, but not inhi-
bition, could be reversed by drug washout, typical of a ligand binding effect.
Conversely, the irreversible nature of the inhibitory effect suggested a non-
ligand binding effect. Treatment with doxorubicin/doxorubicinol reduced
the number of thiols on RyR2, indicative of drug-induced thiol oxidation.
Additionally, doxorubicinol abolished the response of RyR2 to changes in
luminal Ca2þ. Further experiments revealed that the loss of luminal Ca2þ
sensing was due to an interaction between doxOL and CSQ2. Finally, we
found that doxorubicinol inhibits SERCA2a Ca2þ uptake into SR vesicles
and that this was prevented by pretreatment with DTT. These results provide
novel insight into the cellular mechanisms of anthracyclines. We suggest that
by targeting multiple Ca2þ handling proteins in cardiac muscle, anthracy-
clines severely disturb cardiomyocyte Ca2þ homeostasis and that these effects
have an important role in the onset of anthracycline-mediated arrhythmia and
heart failure.
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Contemporary drug screening platforms often fail to resolve hazards related to
chronic toxicity. Many drugs induce a defective homeostatic state, which may
acutely appear ‘normal’, but the chronicity of which provokes phenotypic
dysfunction (latent toxicity). We showed that abnormal Ca2þ signals can be
embedded within perceptibly normal steady-state Ca2þ cycling. In order to
expose these hidden Ca2þ patterns, we developed methods to decrypt intra-
and inter-cellular Ca2þ signals in individual cardiomycytes and in multicellular
populations. In this proof-of-concept study, we used confocal imaging and
pattern analysis of Ca2þ handling in spontaneously contractile Cytiva
